This bill mandates that health plan companies provide coverage for all medical services and prescription medications approved by the FDA for the treatment or slowing of dementia. It also requires coverage for diagnostic testing related to these treatments. Additionally, the bill prohibits health plan companies from employing step therapy protocols for these dementia-related services. The new coverage requirements will take effect on January 1, 2026, for health plans offered, issued, or renewed after that date.

Furthermore, the bill amends Minnesota Statutes 2024, section 256B.0625, subdivision 13f, to include new provisions regarding prior authorization and step therapy protocols. Specifically, it states that any step therapy requirements must comply with sections 62Q.1841 and 62Q.546, and it clarifies that prior authorization or step therapy will not be required for any class of drugs approved for the treatment or prevention of HIV and AIDS. The effective date for these amendments is also set for January 1, 2026.

Statutes affected:
Introduction: 256B.0625